DARA Revenue third quarter 2014 Y/Y Growth Comment
Dara Biosciences, Inc. reported Revenue surge of 188.07% year on year in the third quarter 2014, to $ 1.18 millions, this is lower than Dara Biosciences, Inc.'s recent average Revenue surge of 339.06%.
Looking into third quarter 2014 results within Major Pharmaceutical Preparations industry 10 other companies have achieved higher Revenue growth. While Dara Biosciences, Inc.' s Revenue doubling of 188.07% ranks overall at the positon no. 60 in the third quarter 2014.
Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014
Dara Biosciences,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
263.25 %
63.75 %
-60.51 %
(Jun 30 2013)
DARA's III. Quarter Q/Q Revenue Comment
Dara Biosciences, Inc. achieved in the III. Quarter 2014 below company average Revenue jump of 19.3% quarter on quarter, to $ 1.18 millions.
Within Major Pharmaceutical Preparations industry 75 other companies have achieved higher Revenue quarter on quarter growth. While Dara Biosciences,'s Revenue growth quarter on quarter, overall rank is 750.
Dara Biosciences, Inc. achieved in the III. Quarter 2014 below company average Revenue jump of 19.3% quarter on quarter, to $ 1.18 millions.
Within Major Pharmaceutical Preparations industry 75 other companies have achieved higher Revenue quarter on quarter growth. While Dara Biosciences,'s Revenue growth quarter on quarter, overall rank is 750.
Dara Biosciences,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Sep 30 2015)
12 Months Ending (Jun 30 2015)
12 Months Ending (Mar 31 2015)
12 Months Ending (Sep 30 2014)
12 Months Ending (Jun 30 2014)
Cumulative Revenue 12 Months Ending
$ 3.42
$ 2.65
$ 1.82
$ 1.35
$ 0.89
Y / Y Revenue Growth (TTM)
283.58 %
373.55 %
334.25 %
364.86 %
-
Year on Year Revenue Growth Overall
Ranking
# 60
# 0
# 0
# 0
# 0
Seqeuential Revenue Change (TTM)
29.12 %
45.54 %
34.78 %
51.44 %
59.41 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 273
# 390
# 0
# 0
# 0
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2015 period, Dara Biosciences,'s cumulative twelve months Revenue were $ 3 millions, company would post below average annual Revenue growth of 59.41% year on year, if the fiscal year would end at Sep 30 2015. A slow-down in the Dara Biosciences,'s Revenue growth from the 0.99% growth in Jun 30 2015.
Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 60.
With the quarterly Revenue reported in the Sep 30 2015 period, Dara Biosciences,'s cumulative twelve months Revenue were $ 3 millions, company would post below average annual Revenue growth of 283.58% year on year, if the fiscal year would end at Sep 30 2015. A slow-down in the Dara Biosciences,'s Revenue growth from the 0.99% growth in Jun 30 2015.
Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 60.
About Dara Biosciences, Revenue Growth Rates (DARA), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
313.09%